Literature DB >> 15860117

Molecular cloning and in vitro evaluation of an infectious simian-human immunodeficiency virus containing env of a primary Chinese HIV-1 subtype C isolate.

YingYun Wu1, KunXue Hong, Agnès-Laurence Chenine, James B Whitney, Weidong Xu, QiMin Chen, YunQi Geng, Ruth M Ruprecht, Yiming Shao.   

Abstract

Human immunodeficiency virus (HIV) clade C is the most prevalent subtype and accounts for approximately 50% of all HIV infections worldwide. In China, the prevalent HIV strains are B'/C subtypes, in which the envelope belongs to subtype C. To evaluate potential AIDS vaccines targeting Chinese viral strains in non-human primate models, we constructed an infectious simian-human immunodeficiency virus (SHIV) that expresses most of the envelope of a primary HIV strain, which was isolated from a HIV-positive intravenous drug user from XinJiang province in China. The resulting chimeric SHIV-XJ02170 was infectious in human, rhesus monkey and cynomolgus monkey peripheral blood mononuclear cells (PBMC) and used CCR5 exclusively as coreceptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860117     DOI: 10.1111/j.1600-0684.2005.00098.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  7 in total

1.  Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxis.

Authors:  Nagadenahalli B Siddappa; Girish Hemashettar; Yin Ling Wong; Samir Lakhashe; Robert A Rasmussen; Jennifer D Watkins; Francis J Novembre; François Villinger; James G Else; David C Montefiori; Ruth M Ruprecht
Journal:  J Med Primatol       Date:  2010-11-02       Impact factor: 0.667

2.  Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.

Authors:  R J Song; A-L Chenine; R A Rasmussen; C R Ruprecht; S Mirshahidi; R D Grisson; W Xu; J B Whitney; L M Goins; H Ong; P-L Li; E Shai-Kobiler; T Wang; C M McCann; H Zhang; C Wood; C Kankasa; W E Secor; H M McClure; E Strobert; J G Else; R M Ruprecht
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Molecularly cloned SHIV-CN97001: a replication-competent, R5 simian/human immunodeficiency virus containing env of a primary Chinese HIV-1 clade C isolate.

Authors:  Qiang Liu; Yue Li; GuiBo Yang; JieJie Dai; Ruth M Ruprecht; Yiming Shao
Journal:  J Med Primatol       Date:  2011-09-06       Impact factor: 0.667

4.  Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.

Authors:  Nagadenahalli B Siddappa; Ruijiang Song; Victor G Kramer; Agnès-Laurence Chenine; Vijayakumar Velu; Helena Ong; Robert A Rasmussen; Ricky D Grisson; Charles Wood; Hong Zhang; Chipeppo Kankasa; Rama Rao Amara; James G Else; Francis J Novembre; David C Montefiori; Ruth M Ruprecht
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

5.  Generation of lineage-related, mucosally transmissible subtype C R5 simian-human immunodeficiency viruses capable of AIDS development, induction of neurological disease, and coreceptor switching in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Agegnehu Gettie; Michael S Seaman; Kasi Russell-Lodrigue; James Blanchard; Susan Westmoreland; Cecilia Cheng-Mayer
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

Review 6.  Coreceptor use in nonhuman primate models of HIV infection.

Authors:  Silvana Tasca Sina; Wuze Ren; Cecilia Cheng-Mayer
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

7.  SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.

Authors:  Michael Humbert; Robert A Rasmussen; Ruijiang Song; Helena Ong; Prachi Sharma; Agnès L Chenine; Victor G Kramer; Nagadenahalli B Siddappa; Weidong Xu; James G Else; Francis J Novembre; Elizabeth Strobert; Shawn P O'Neil; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2008-10-17       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.